These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 29696695)

  • 41. The facile and visualizable identification of broad-spectrum inhibitors of MDM2/p53 using co-expressed protein complexes.
    Yang Y; Dong Z; Hu H; Peng J; Sheng Y; Tong Y; Yuan S; Li Z; Yang J; Wells T; Qu Y; Farrell NP; Liu Y
    Analyst; 2019 Jun; 144(12):3773-3781. PubMed ID: 31089613
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Identification of antipsychotic drug fluspirilene as a potential p53-MDM2 inhibitor: a combined computational and experimental study.
    Patil SP; Pacitti MF; Gilroy KS; Ruggiero JC; Griffin JD; Butera JJ; Notarfrancesco JM; Tran S; Stoddart JW
    J Comput Aided Mol Des; 2015 Feb; 29(2):155-63. PubMed ID: 25377899
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Structure of the MDM2 oncoprotein bound to the p53 tumor suppressor transactivation domain.
    Kussie PH; Gorina S; Marechal V; Elenbaas B; Moreau J; Levine AJ; Pavletich NP
    Science; 1996 Nov; 274(5289):948-53. PubMed ID: 8875929
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Molecular dynamics simulations studies and free energy analysis on inhibitors of MDM2-p53 interaction.
    Niu RJ; Zheng QC; Zhang JL; Zhang HX
    J Mol Graph Model; 2013 Nov; 46():132-9. PubMed ID: 24211465
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Multiple peptide conformations give rise to similar binding affinities: molecular simulations of p53-MDM2.
    Dastidar SG; Lane DP; Verma CS
    J Am Chem Soc; 2008 Oct; 130(41):13514-5. PubMed ID: 18800837
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Quantitative lid dynamics of MDM2 reveals differential ligand binding modes of the p53-binding cleft.
    Showalter SA; Bruschweiler-Li L; Johnson E; Zhang F; Brüschweiler R
    J Am Chem Soc; 2008 May; 130(20):6472-8. PubMed ID: 18435534
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The Mechanism of p53 Rescue by SUSP4.
    Kim DH; Lee C; Lee SH; Kim KT; Han JJ; Cha EJ; Lim JE; Cho YJ; Hong SH; Han KH
    Angew Chem Int Ed Engl; 2017 Jan; 56(5):1278-1282. PubMed ID: 28000315
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Molecular interaction fields and 3D-QSAR studies of p53-MDM2 inhibitors suggest additional features of ligand-target interaction.
    Dezi C; Carotti A; Magnani M; Baroni M; Padova A; Cruciani G; Macchiarulo A; Pellicciari R
    J Chem Inf Model; 2010 Aug; 50(8):1451-65. PubMed ID: 20726601
    [TBL] [Abstract][Full Text] [Related]  

  • 49. An Effective Virtual Screening Protocol To Identify Promising p53-MDM2 Inhibitors.
    Tortorella P; Laghezza A; Durante M; Gomez-Monterrey I; Bertamino A; Campiglia P; Loiodice F; Daniele S; Martini C; Agamennone M
    J Chem Inf Model; 2016 Jun; 56(6):1216-27. PubMed ID: 27269808
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Oxazoloisoindolinones with in vitro antitumor activity selectively activate a p53-pathway through potential inhibition of the p53-MDM2 interaction.
    Soares J; Pereira NA; Monteiro Â; Leão M; Bessa C; Dos Santos DJ; Raimundo L; Queiroz G; Bisio A; Inga A; Pereira C; Santos MM; Saraiva L
    Eur J Pharm Sci; 2015 Jan; 66():138-47. PubMed ID: 25312347
    [TBL] [Abstract][Full Text] [Related]  

  • 51. FOLICation: engineering approved drugs as potential p53-MDM2 interaction inhibitors for cancer therapy.
    Patil SP
    Med Hypotheses; 2013 Dec; 81(6):1104-7. PubMed ID: 24210632
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Identification of EhICP1, a chagasin-like cysteine protease inhibitor of Entamoeba histolytica.
    Riekenberg S; Witjes B; Sarić M; Bruchhaus I; Scholze H
    FEBS Lett; 2005 Mar; 579(7):1573-8. PubMed ID: 15757643
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Development of E3-substrate (MDM2-p53)-binding inhibitors: structural aspects.
    Fry DC; Graves B; Vassilev LT
    Methods Enzymol; 2005; 399():622-33. PubMed ID: 16338385
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Efficient reactivation of p53 in cancer cells by a dual MdmX/Mdm2 inhibitor.
    Qin L; Yang F; Zhou C; Chen Y; Zhang H; Su Z
    J Am Chem Soc; 2014 Dec; 136(52):18023-33. PubMed ID: 25453499
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The C-terminal SAM domain of p73 binds to the N terminus of MDM2.
    Neira JL; Díaz-García C; Prieto M; Coutinho A
    Biochim Biophys Acta Gen Subj; 2019 Apr; 1863(4):760-770. PubMed ID: 30735716
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A second p53 binding site in the central domain of Mdm2 is essential for p53 ubiquitination.
    Ma J; Martin JD; Zhang H; Auger KR; Ho TF; Kirkpatrick RB; Grooms MH; Johanson KO; Tummino PJ; Copeland RA; Lai Z
    Biochemistry; 2006 Aug; 45(30):9238-45. PubMed ID: 16866370
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Energetic Landscape of MDM2-p53 Interactions by Computational Mutagenesis of the MDM2-p53 Interaction.
    Thayer KM; Beyer GA
    PLoS One; 2016; 11(3):e0147806. PubMed ID: 26992014
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Flexibility is important for inhibition of the MDM2/p53 protein-protein interaction by cyclic β-hairpins.
    Danelius E; Pettersson M; Bred M; Min J; Waddell MB; Guy RK; Grøtli M; Erdelyi M
    Org Biomol Chem; 2016 Nov; 14(44):10386-10393. PubMed ID: 27731454
    [TBL] [Abstract][Full Text] [Related]  

  • 59. MDM2 small-molecule antagonist RG7112 activates p53 signaling and regresses human tumors in preclinical cancer models.
    Tovar C; Graves B; Packman K; Filipovic Z; Higgins B; Xia M; Tardell C; Garrido R; Lee E; Kolinsky K; To KH; Linn M; Podlaski F; Wovkulich P; Vu B; Vassilev LT
    Cancer Res; 2013 Apr; 73(8):2587-97. PubMed ID: 23400593
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The cis conformation of proline leads to weaker binding of a p53 peptide to MDM2 compared to trans.
    Zhan YA; Ytreberg FM
    Arch Biochem Biophys; 2015 Jun; 575():22-9. PubMed ID: 25840370
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.